Flagship Invests £100 million to Build AI-Driven Pharmaceutical Company in the UK

Written by

in

Flagship Ventures plans to invest £100 million to build an AI-driven pharmaceutical company in the UK. The article mainly explains the platform nature of Global Banking & Finance Review® and its content disclaimer, and does not provide details on the investment target, funding arrangements beyond the stated amount, or project progress.

Source:globalbankingandfinance.com · Read Original

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *